SCOTTSDALE, Ariz., January 25, 2023 — The Symposium on Regenerative Medicine & Surgery will explore the field of biologics along with the latest in regenerative immunotherapies, oncology, regulatory issues, cell-free therapies, tissue engineering and 3D printing.
Mayo Clinic’s Center for Regenerative Biotherapeutics is sponsoring this symposium as part of its objective of training the future regenerative workforce.
“Regenerative medicine and biotherapeutics are the health care of tomorrow. Education is the key to advancing new technologies that address rare and complex conditions for patients with unmet needs,” says Richard Hayden, M.D., course director, Mayo Clinic Symposium on Regenerative Medicine & Surgery. “Mayo Clinic is one of the few academic medical centers that is developing coursework in this evolving field. The symposium is a rare opportunity to learn regenerative science concepts from the experts.”
Mayo Clinic is honored to confirm that, Shinya Yamanaka, M.D., Ph.D., one of the world’s most renowned experts in the field, will lead off the event with his keynote address. His groundbreaking discovery of induced pluripotent stem cells (iPS cells) — reprogramming cells to differentiate into any type of cell in the body — earned him the Nobel Prize in Physiology or Medicine in 2012.
“In the presentation, I would like to introduce recent progress and future prospects of medical applications using iPS cells in Japan, as well as challenges we are facing,” says Dr. Yamanaka. “Regenerative medicine using iPS cells is expected to bring to reality innovative medical treatments that go beyond conventional symptomatic therapies to actually help patients regenerate lost functions. On the other hand, drug discovery using patient iPS cells is expected to help deliver drugs that are truly safe and effective.
“Understanding induced pluripotent stem cells is vitally important for the current and next generation of physicians and scientists,” says Richard Hayden, M.D., course director for the Mayo Clinic Symposium on Regenerative Medicine & Surgery 2023. “Induced pluripotent stem cells are tools for generating a vast supply of human tissue vital to understanding disease. Researchers and clinicians who are trained to use this tool may be equipped to provide new regenerative solutions for complex diseases, particularly those with no therapeutic options.”
The symposium will address topics such as biologics — medicines derived from human sources, such as cells, blood, enzymes, tissues, genes or genetically engineered cells. It also will feature the latest in regenerative immunotherapies, oncology, regulatory issues, cell-free therapies, tissue engineering and 3D printing. Conference attendees may earn 9.25 continuing medical education credits.
Additional keynote speakers include:
- Peter Marks, M.D., Ph.D., director of the Center for Biologics Evaluation and Research at the Food and Drug Administration.
- Bruce Levine, Ph.D., immediate past president of the International Society for Cell & Gene Therapy. Dr. Levin also is founding director of the Clinical Cell and Vaccine Production Facility in the Department of Pathology and Laboratory Medicine and the Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania.
- Raghu Kalluri, M.D., Ph.D.,professor and chairman of the Department of Cancer Biology and the director of the Metastasis Research Center at MD Anderson Cancer Center.
- Harald Ott, M.D., associate professor of surgery at Harvard Medical School and a thoracic surgeon at Massachusetts General Hospital.
Register now for the Mayo Clinic Symposium on Regenerative Medicine & Surgery 2023 held April 3-5, at the Westin Kierland Resort & Spa in Scottsdale, Arizona.
About Mayo Clinic
Mayo Clinic is a nonprofit organization committed to innovation in clinical practice, education and research, and providing compassion, expertise and answers to everyone who needs healing. Visit the Mayo Clinic News Network for additional Mayo Clinic news. For information on COVID-19, including Mayo Clinic’s Coronavirus Map tracking tool, which has 14-day forecasting on COVID-19 trends, visit the Mayo Clinic COVID-19 Resource Center.
About Mayo Clinic’s Center for Regenerative Biotherapeutics
Mayo Clinic’s Center for Regenerative Biotherapeutics seeks to integrate, develop and deploy new regenerative medicine products and services that continually differentiate Mayo’s practice to draw patients from around the world for complex care. Learn more on Mayo Clinic’s Center for Regenerative Medicine website.